MKN7Homo sapiens (Human)Cancer cell line
Also known as: MKN 7, MKN-7
Quick Overview
Human gastric cancer cell line with known genetic alterations and drug sensitivity profiles.
Detailed Summary
Research Applications
Key Characteristics
Basic Information
Database ID | CVCL_1417 |
---|---|
Species | Homo sapiens (Human) |
Tissue Source | Lymph node[UBERON:UBERON_0000029] |
Donor Information
Age | 39 |
---|---|
Age Category | Adult |
Sex | Male |
Race | asian |
Disease Information
Disease | Gastric tubular adenocarcinoma |
---|---|
Lineage | Esophagus/Stomach |
Subtype | Tubular Stomach Adenocarcinoma |
OncoTree Code | TSTAD |
DepMap Information
Source Type | RIKEN |
---|---|
Source ID | ACH-000678_source |
Known Sequence Variations
Type | Gene/Protein | Description | Zygosity | Note | Source |
---|---|---|---|---|---|
MutationSimple | TP53 | p.Pro278Ser (c.832C>T) | Unspecified | - | PubMed=24662767, PubMed=21602893 |
Haplotype Information (STR Profile)
Short Tandem Repeat (STR) profile for cell line authentication.
Loading gene expression data...
Publications
Pan-cancer proteomic map of 949 human cell lines.";
Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.
Cancer Cell 40:835-849.e8(2022).
Quantitative proteomics of the Cancer Cell Line Encyclopedia.";
Sellers W.R., Gygi S.P.
Cell 180:387-402.e16(2020).
Next-generation characterization of the Cancer Cell Line Encyclopedia.
Sellers W.R.
Nature 569:503-508(2019).
An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.
Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.
Cancer Res. 79:1263-1273(2019).
Forty-nine gastric cancer cell lines with integrative genomic profiling for development of c-MET inhibitor.
Kragh M., Horak I.D., Chung H.C., Rha S.Y.
Int. J. Cancer 143:151-159(2018).
A landscape of pharmacogenomic interactions in cancer.";
Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
Cell 166:740-754(2016).
TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.
Loewer M., Sahin U., Castle J.C.
Genome Med. 7:118.1-118.7(2015).
Parallel genome-scale loss of function screens in 216 cancer cell lines for the identification of context-specific genetic dependencies.
Golub T.R., Root D.E., Hahn W.C.
Sci. Data 1:140035-140035(2014).
A resource for cell line authentication, annotation and quality control.
Neve R.M.
Nature 520:307-311(2015).
A comprehensive transcriptional portrait of human cancer cell lines.
Settleman J., Seshagiri S., Zhang Z.-M.
Nat. Biotechnol. 33:306-312(2015).
Molecular integrative clustering of Asian gastric cell lines revealed two distinct chemosensitivity clusters.
Yang H.H., Lee M.A.
PLoS ONE 9:E111146-E111146(2014).
Integrated exome and transcriptome sequencing reveals ZAK isoform usage in gastric cancer.
Firestein R., Zhang Z.-M.
Nat. Commun. 5:3830.1-3830.8(2014).
A compensatory role of NF-kappaB to p53 in response to 5-FU-based chemotherapy for gastric cancer cell lines.
Sato K., Iwaya T., Koeda K., Wakabayashi G.
PLoS ONE 9:E90155-E90155(2014).
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.
Nature 483:603-607(2012).
JFCR39, a panel of 39 human cancer cell lines, and its application in the discovery and development of anticancer drugs.
Kong D.-X., Yamori T.
Bioorg. Med. Chem. 20:1947-1951(2012).
A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.
Haber D.A.
Cancer Res. 70:2158-2164(2010).
Signatures of mutation and selection in the cancer genome.";
Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.
Nature 463:893-898(2010).
p53-defective tumors with a functional apoptosome-mediated pathway: a new therapeutic target.
Tomoda H., Yamori T., Tsuruo T.
J. Natl. Cancer Inst. 97:765-777(2005).
Chemosensitivity profile of cancer cell lines and identification of genes determining chemosensitivity by an integrated bioinformatical approach using cDNA arrays.
Yamori T.
Mol. Cancer Ther. 4:399-412(2005).
Screening of DNA copy-number aberrations in gastric cancer cell lines by array-based comparative genomic hybridization.
Okanoue T., Inazawa J.
Cancer Sci. 96:100-110(2005).
Molecular characteristics of eight gastric cancer cell lines established in Japan.
Yokozaki H.
Pathol. Int. 50:767-777(2000).
Thromboplastic and fibrinolytic activities of cultured human gastric cancer cell lines.
Naito S., Inoue S., Kinjo M., Tanaka K.
Gann 74:240-247(1983).
Comparison of seven cell lines derived from human gastric carcinomas.
Motoyama T., Hojo H., Watanabe H.
Acta Pathol. Jpn. 36:65-83(1986).
p53 gene mutations in gastric cancer metastases and in gastric cancer cell lines derived from metastases.
Nakatani K., Nakano H., Sugimura T., Terada M.
Cancer Res. 51:5800-5805(1991).
Gastric tumor cell lines.";
Sekiguchi M., Suzuki T.
(In book chapter) Atlas of human tumor cell lines; Hay R.J., Park J.-G., Gazdar A.F. (eds.); pp.287-316; Academic Press; New York; USA (1994).